Transthoracic echocardiographic and thoracic electrical bioimpedance derived hemodynamic indices versus transpulmonary thermodilution derived hemodynamci indices in shock patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045861

Enrollment

Unknown

Registered

2021-04-25

Start date

2021-04-12

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shock

Interventions

Gold Standard:Hemodynamic measurement by pulmonary thermodilution

Index test:Noninvasive&#32

hemodynamic&#32

monitoring

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Shock patients meet at least one of the following conditions: (1) HR > 100 times/min; (2) SBP 2mmol/l, renal dysfunction (urine volume < 0.5ml/kg.h or changes in biochemical indicators of acute kidney injury); (4) Skin mottling; (5) CVP < 10mmHg or PAWP < 12mmHg.

Exclusion criteria

Exclusion criteria: 1. Patients aged < 18 years, or pregnant women; 2. Patients with intracranial hypertension, brain death, or brain death that may occur within 24 hours; 3. Patients with severe arrhythmia, heart failure, pulmonary edema, or myocardial infarction within the previous month.

Design outcomes

Primary

Measure	Time frame
hemodynamic parameters;SEN, SPE, ACC, AUC of ROC;	—

Secondary

Measure	Time frame
hemodynamic parameters;hemodynamic parameters;	—

Countries

China

Contacts

Public ContactSi Xiang

The First Affiliated Hospital of Sun Yat-Sen University

james_sixiang@163.com+86 15920130469

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026